Yokukansan contains compounds that antagonize the 5-HT3 receptor

被引:17
|
作者
Nakamura, Yukiko [1 ]
Ishida, Yusuke [1 ]
Kondo, Makoto [1 ]
Shimada, Shoichi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
Yokukansan; Yi-Gan San; Serotonin receptor; Ion channel; Antagonist; 5-HT3; YI-GAN-SAN; GEISSOSCHIZINE METHYL-ETHER; HUMAN-BRAIN; PSYCHOLOGICAL SYMPTOMS; TISSUE DISTRIBUTION; ACTIVE METABOLITE; ANTICANCER DRUG; LEWY BODIES; DEMENTIA; EXPRESSION;
D O I
10.1016/j.phymed.2018.04.034
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: We recently focused on alkaloids in Uncaria hook (a constituent of the Kampo medicine, yokukansan) and identified the pharmacological action of geissoschizine methyl ether on several G protein-coupled receptors. However, the functions of other identified alkaloids in Uncaria hook, including hirsutine, hirsuteine, rhynchophylline, isorhynchophylline, corynoxeine, isocorynoxeine, are not clear. Purpose: To evaluate the effect of seven alkaloids in Uncaria hook (hirsutine, hirsuteine, rhynchophylline, isorhynchophylline, corynoxeine, isocorynoxeine and geissoschizine methyl ether) on the hydroxytryptamine type3 (5-HT3) receptor ion channel. Study design: We examined the effect of these alkaloids on the current of human 5-HT3 receptors expressed in Xenopus laevis oocytes. Methods: The human 5-HT(3)A subunit alone for the 5-HT(3)A receptor, or 5-HT(3)A and 5-HT3B subunits for the 5HT(3)AB receptor, were expressed in Xenopus laevis oocytes. The 5-HT current was measured with or without alkaloid application using a two-electrode voltage clamp. Results: Each alkaloid, except for geissoschizine methyl ether, weakly inhibited the 5-HT-mediated 5-HT(3)A and/or 5-HT(3)AB receptor current, but co-application of these seven alkaloids inhibited the current strongly. Conclusion: Each alkaloid contributes to antagonism of the 5-HT3 receptor.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 50 条
  • [1] Yokukansan-induced reduction of ethanol preference is associated with antagonism of 5-HT3 receptors
    Nakamura, Yukiko
    Kondo, Makoto
    Koyama, Yoshihisa
    Shimada, Shoichi
    PHYTOMEDICINE, 2019, 59
  • [2] SR 57227A is a partial agonist/partial antagonist of 5-HT3 receptor and inhibits subsequent 5-HT- or SR 57227A-induced 5-HT3 receptor current
    Nakamura, Yukiko
    Kondo, Makoto
    Koyama, Yoshihisa
    Shimada, Shoichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 508 (02) : 590 - 596
  • [3] THE SELECTIVITY OF THE CHANNEL COUPLED TO THE 5-HT3 RECEPTOR
    YAKEL, JL
    SHAO, XM
    JACKSON, MB
    BRAIN RESEARCH, 1990, 533 (01) : 46 - 52
  • [4] Direct modification of the 5-HT3 receptor current by some anticancer drugs
    Nakamura, Yukiko
    Ishida, Yusuke
    Kondo, Makoto
    Shimada, Shoichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 821 : 21 - 28
  • [5] THE 5-HT3 RECEPTOR-CHANNEL
    JACKSON, MB
    YAKEL, JL
    ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 : 447 - 468
  • [6] 5-HT3 receptors
    Thompson, A. J.
    Lummis, S. C. R.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (28) : 3615 - 3630
  • [7] 5-Chloroindole: a potent allosteric modulator of the 5-HT3 receptor
    Newman, Amy S.
    Batis, Nikolaos
    Grafton, Gillian
    Caputo, Francesca
    Brady, Catherine A.
    Lambert, Jeremy J.
    Peters, John A.
    Gordon, John
    Brain, Keith L.
    Powell, Andrew D.
    Barnes, Nicholas M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (06) : 1228 - 1238
  • [8] Fluoxetine increased adult neurogenesis is mediated by 5-HT3 receptor
    Olivas-Cano, I
    Rodriguez-Andreu, J. M.
    Blasco-Ibanez, J. M.
    Crespo, C.
    Nacher, J.
    Varea, E.
    NEUROSCIENCE LETTERS, 2023, 795
  • [9] Recent developments in 5-HT3 receptor pharmacology
    Thompson, Andrew J.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (02) : 100 - 109
  • [10] Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions
    Machu, Tina K.
    PHARMACOLOGY & THERAPEUTICS, 2011, 130 (03) : 338 - 347